Intensive care medicine

Asthma

Ecology

Biology

Clinical trial

Drug

Repurposing

Internal medicine

Pharmacology

Drug repositioning

Medicine

Allergic asthma

Randomized controlled trial

The Journal of Allergy and Clinical Immunology In Practice

Drug repurposing is one ofthe major fields ofValue-Added Medicines.lt involves the investigation and evaluation of existing drugs for new therapeutic purposes that address unmet healthcare needs.There are several unmet needs in allergic rhinitis that could be improved by drug repurposing.This could be game-changing for disease management.The current medications for allergic rhinitis are centered around a continuous long-term treatment, and medication registration is based on randomized controlled trials carried out for a mínimum of 14 days with adherence 2: 70%.A new way of treating allergic rhinitis is to propase an as-needed treatment depending on symptoms, rather than the classical continuous treatment.This rostrum will discuss the existing clinical trials on as-needed treatment for allergic rhinitis and real-world data obtained by the mobile health app MASK-air that has a focus on digitally-enabled, O patient-centered care pathways.

The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis